Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

21
Number of overlapping holdings
18.9%
% of BMED's 121 holdings also in FBT
70.0%
% of FBT's 31 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BMED |
Weight in FBT |
Overlap | |
---|---|---|---|---|
AMGEN INC | 3.1% | 3.1% | 3.1% | |
ARGENX SE ADR | 3.0% | 3.4% | 3.0% | |
VERTEX PHARMACEUTICALS INC | 2.7% | 3.2% | 2.7% | |
BIOMARIN PHARMACEUTICAL INC | 2.0% | 3.6% | 2.0% | |
GILEAD SCIENCES INC | 1.5% | 3.2% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to FBT
BOSTON SCIENTIFIC CORP | 3.3% | |
ELI LILLY & CO | 3.2% | |
AMERISOURCEBERGEN CORP | 3.0% | |
WEST PHARMACEUTICAL SERVICES | 2.8% | |
NOVO NORDISK A/S-B | 2.4% | |
COOPER COS INC/THE | 2.0% | |
INTUITIVE SURGICAL INC | 1.8% | |
STERIS PLC | 1.8% | |
ABCAM PLC SPONSORED ADR | 1.7% | |
ALIGN TECHNOLOGY INC | 1.7% |
BMED Underweight Relative to FBT
GRIFOLS SA-ADR | -3.9% | |
IQVIA HOLDINGS INC | -3.7% | |
ULTRAGENYX PHARMACEUTICAL IN | -3.6% | |
BIONTECH SE SPONSORED ADR | -3.6% | |
CHARLES RIVER LABORATORIES | -3.5% | |
AGIOS PHARMACEUTICALS INC | -3.4% | |
GENMAB A/S SPONSORED ADR | -3.3% | |
ACADIA PHARMACEUTICALS INC | -3.3% | |
REGENERON PHARMACEUTICALS | -3.3% | |
MODERNA, INC. | -3.2% |